These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2955413)

  • 1. Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters.
    Morin JE; Lubeck MD; Barton JE; Conley AJ; Davis AR; Hung PP
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4626-30. PubMed ID: 2955413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs.
    Chengalvala M; Lubeck MD; Davis AR; Mizutani S; Molnar-Kimber K; Morin J; Hung PP
    Vaccine; 1991 Jul; 9(7):485-90. PubMed ID: 1832806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of high expression adenovirus-hepatitis B virus recombinant vaccines in dogs.
    Chengalvala MV; Bhat BM; Bhat R; Lubeck MD; Mizutani S; Davis AR; Hung PP
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():125-31. PubMed ID: 8113721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication and immunogenicity of Ad7-, Ad4-, and Ad5-hepatitis B virus surface antigen recombinants, with or without a portion of E3 region, in chimpanzees.
    Chengalvala MV; Bhat BM; Bhat RA; Dheer SK; Lubeck MD; Purcell RH; Murthy KK
    Vaccine; 1997 Feb; 15(3):335-9. PubMed ID: 9139496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression of hepatitis B virus antigens by a non-defective adenovirus vaccine vector.
    Ye WW; Mason BB; Chengalvala M; Cheng SM; Zandle G; Lubeck MD; Lee SG; Mizutani S; Davis AR; Hung PP
    Arch Virol; 1991; 118(1-2):11-27. PubMed ID: 1828660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccine.
    Tacket CO; Losonsky G; Lubeck MD; Davis AR; Mizutani S; Horwith G; Hung P; Edelman R; Levine MM
    Vaccine; 1992; 10(10):673-6. PubMed ID: 1523878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of recombinant hepatitis B vaccine.
    Ohmura T; Ohmizu A; Sumi A; Ohtani W; Uemura Y; Arimura H; Nishida M; Kohama Y; Okabe M; Mimura T
    Biochem Biophys Res Commun; 1987 Dec; 149(3):1172-8. PubMed ID: 2962578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus.
    Lubeck MD; Davis AR; Chengalvala M; Natuk RJ; Morin JE; Molnar-Kimber K; Mason BB; Bhat BM; Mizutani S; Hung PP
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6763-7. PubMed ID: 2570422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus vectored vaccines.
    Natuk RJ; Davis AR; Chanda PK; Lubeck MD; Chengalvala M; Murthy SC; Wade MS; Dheer SK; Bhat BM; Murthy KK
    Dev Biol Stand; 1994; 82():71-7. PubMed ID: 7958485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of HBV surface antigen or HIV envelope protein using recombinant adenovirus vectors.
    Hung PP; Morin JE; Lubeck MD; Barton JE; Molnar-Kimber KL; Mason BB; Dheer SK; Jarocki-Witek V; Kostek B; Zandle G
    Nat Immun Cell Growth Regul; 1988; 7(3):135-43. PubMed ID: 3173369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helper independent recombinant adenovirus vectors: expression of HIV env or HBV surface antigen.
    Chanda PK; Natuk RJ; Dheer SK; Lubeck MD; Bhat BM; Mason BB; Greenberg L; Mizutani S; Davis AR; Hung PP
    Int Rev Immunol; 1990; 7(1):67-77. PubMed ID: 2132880
    [No Abstract]   [Full Text] [Related]  

  • 12. Defective and nondefective adenovirus vectors for expressing foreign genes in vitro and in vivo.
    Levrero M; Barban V; Manteca S; Ballay A; Balsamo C; Avantaggiati ML; Natoli G; Skellekens H; Tiollais P; Perricaudet M
    Gene; 1991 May; 101(2):195-202. PubMed ID: 1829048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplified and persistent immune responses generated by single-cycle replicating adenovirus vaccines.
    Crosby CM; Nehete P; Sastry KJ; Barry MA
    J Virol; 2015 Jan; 89(1):669-75. PubMed ID: 25355873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of a purified hepatitis B virus vaccine prepared by using recombinant DNA technology.
    Zahradnik JM; Couch RB; Gerin JL
    J Infect Dis; 1987 May; 155(5):903-8. PubMed ID: 2951449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses to recombinant, yeast-derived hepatitis B vaccine in teenage New Zealand children.
    Milne A; Moyes CD; Allwood GK; Pearce NE; Krugman S
    N Z Med J; 1988 Feb; 101(840):67-9. PubMed ID: 2967940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response to hepatitis B vaccine in premature neonates.
    Chawareewong S; Jirapongsa A; Lokaphadhana K
    Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):39-40. PubMed ID: 1835140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
    Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
    Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses to hepatitis B virus surface and core antigens in mice, monkeys, and pigs after Accell particle-mediated DNA immunization.
    Fuller JT; Fuller DH; McCabe D; Haynes JR; Widera G
    Ann N Y Acad Sci; 1995 Nov; 772():282-4. PubMed ID: 8546409
    [No Abstract]   [Full Text] [Related]  

  • 19. Yeast recombinant hepatitis B vaccine.
    Hilleman MR
    Infection; 1987; 15(1):3-7. PubMed ID: 2437037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative analysis of the humoral immune response to the "a" determinant of HBs antigen after inoculation with plasma-derived or recombinant vaccine.
    Waters JA; O'Rourke SM; Richardson SC; Papaevangelou G; Thomas HC
    J Med Virol; 1987 Feb; 21(2):155-60. PubMed ID: 2434612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.